171 related articles for article (PubMed ID: 34095460)
21. Intrinsic Genetic and Transcriptomic Patterns Reflect Tumor Immune Subtypes Facilitating Exploring Possible Combinatory Therapy.
Xu Y; Li D; Liu Z; Gibbs DL; Xie L; Qin G
Front Mol Biosci; 2020; 7():53. PubMed ID: 32391377
[TBL] [Abstract][Full Text] [Related]
22. Novel Risk Classification Based on Pyroptosis-Related Genes Defines Immune Microenvironment and Pharmaceutical Landscape for Hepatocellular Carcinoma.
Wang J; Wang Y; Steffani M; Stöß C; Ankerst D; Friess H; Hüser N; Hartmann D
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053610
[TBL] [Abstract][Full Text] [Related]
23. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Study of Tumor Immune Microenvironment and Relevant Genes in Hepatocellular Carcinoma Identifies Potential Prognostic Significance.
Chen W; Zhang X; Bi K; Zhou H; Xu J; Dai Y; Diao H
Front Oncol; 2020; 10():554165. PubMed ID: 33072579
[No Abstract] [Full Text] [Related]
25. Crosslink among phosphatidylinositol-3 kinase/Akt, PTEN and STAT-5A signaling pathways post liposomal galactomannan hepatocellular carcinoma therapy.
Abdel-Megeed RM; Abd El-Alim SH; Arafa AF; Matloub AA; Farrag AERH; Darwish AB; Abdel-Hamid AZ; Kadry MO
Toxicol Rep; 2020; 7():1531-1541. PubMed ID: 33251120
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2.
Ren W; Wu S; Wu Y; Liu T; Zhao X; Li Y
Cell Death Dis; 2019 Apr; 10(5):333. PubMed ID: 30988277
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
Shen J; Tsoi H; Liang Q; Chu ES; Liu D; Yu AC; Chan TF; Li X; Sung JJ; Wong VW; Yu J
Oncogene; 2016 Dec; 35(49):6271-6280. PubMed ID: 27132506
[TBL] [Abstract][Full Text] [Related]
28. KPNA2-Associated Immune Analyses Highlight the Dysregulation and Prognostic Effects of GRB2, NRAS, and Their RNA-Binding Proteins in Hepatocellular Carcinoma.
Zhang X; Zhang J; Gao F; Fan S; Dai L; Zhang J
Front Genet; 2020; 11():593273. PubMed ID: 33193737
[TBL] [Abstract][Full Text] [Related]
29. Inhibited PTHLH downstream leukocyte adhesion-mediated protein amino acid N-linked glycosylation coupling Notch and JAK-STAT cascade to iron-sulfur cluster assembly-induced aging network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by systems-theoretical analysis.
Wang L; Huang J; Jiang M; Lin H; Qi L; Diao H
Integr Biol (Camb); 2012 Oct; 4(10):1256-62. PubMed ID: 22955522
[TBL] [Abstract][Full Text] [Related]
30. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
[TBL] [Abstract][Full Text] [Related]
31. Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat Stress.
Thompson SM; Callstrom MR; Jondal DE; Butters KA; Knudsen BE; Anderson JL; Lien KR; Sutor SL; Lee JS; Thorgeirsson SS; Grande JP; Roberts LR; Woodrum DA
PLoS One; 2016; 11(9):e0162634. PubMed ID: 27611696
[TBL] [Abstract][Full Text] [Related]
32. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
Chen W; Tang D; Ou M; Dai Y
DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
[TBL] [Abstract][Full Text] [Related]
33. Identification of an immune subtype predicting survival risk and immune activity in hepatocellular carcinoma.
Zhao F; Xu N; Yang J; Li B; Shi J; Zheng Y; Xu L
Aging (Albany NY); 2021 May; 13():. PubMed ID: 33946047
[TBL] [Abstract][Full Text] [Related]
34. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
[TBL] [Abstract][Full Text] [Related]
35. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
36. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
[TBL] [Abstract][Full Text] [Related]
38. Construction of a prognostic model based on nine immune-related genes and identification of small molecule drugs for hepatocellular carcinoma (HCC).
Zhang J; Chen G; Zhang J; Zhang P; Ye Y
Am J Transl Res; 2020; 12(9):5108-5130. PubMed ID: 33042409
[TBL] [Abstract][Full Text] [Related]
39. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
Singh AR; Joshi S; Burgoyne AM; Sicklick JK; Ikeda S; Kono Y; Garlich JR; Morales GA; Durden DL
Mol Cancer Ther; 2016 Nov; 15(11):2553-2562. PubMed ID: 27496136
[TBL] [Abstract][Full Text] [Related]
40. Autophagy-related genes prognosis signature as potential predictive markers for immunotherapy in hepatocellular carcinoma.
Mao D; Zhang Z; Zhao X; Dong X
PeerJ; 2020; 8():e8383. PubMed ID: 31988807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
